Wide Ranks

LENZ

LENZ Therapeutics, Inc.

37.30

Top Statistics
Market Cap 1 B Forward PE -20.79 Revenue Growth 0.00 %
Current Ratio 28.63 Trailing PE 0.0000 Earnings Growth 0.00 %
Profit Margins 0.00 % Peg Ratio Dividend Yield 0.00 %
Enterprice / EBITA -11.86 Enterprise / Revenue Price To Sales Trailing12 Months
Profitability
Profit Margins 0.00 % Operating Margins
Balance Sheet
Total Cash 217 M Total Cash Per Share 7.89 Total Debt 1 M
Total Debt To Equity 0.7330 Current Ratio 28.63 Book Value Per Share 7.83
All Measures
Short Ratio 1200.00 % Message Board Id finmb_370131860 Shares Short Prior Month 2 M
Return On Equity -0.4190 City Del Mar Uuid d24b15aa-881d-34ad-927c-2442ad2e5710
Previous Close 36.25 First Trade Date Epoch Utc 1 B Book Value 7.83
Total Debt 1 M Volume 102186 Price To Book 4.76
Last Split Date 1 B Fifty Two Week Low 2.12 Total Cash Per Share 7.89
Shares Short Previous Month Date 1 B Target Median Price 38.00 Max Age 86400
Sand P52 Week Change 0.3133 Last Dividend Value 7.21 Target Mean Price 39.29
Net Income To Common -60809000 Implied Shares Outstanding 27 M Trailing Peg Ratio None
Last Fiscal Year End 1 B Average Daily Volume10 Day 122270 Average Volume10days 122270
Total Cash 217 M Next Fiscal Year End 1 B Held Percent Insiders 0.0279
Trailing PE 0.0000 Date Short Interest 1 B Most Recent Quarter 1 B
Regular Market Previous Close 36.25 Target Low Price 36.00 Gmt Off Set Milliseconds -18000000
Fifty Day Average 28.20 Open 36.38 Free Cashflow -49261752
State CA Dividend Yield 0.00 % Return On Assets -0.2703
Time Zone Short Name EST Trailing Eps -2.74 Day Low 35.94
Address1 445 Marine View Avenue Shares Outstanding 27 M Price Hint 2
Target High Price 45.00 Website https://www.lenz-tx.com 52 Week Change 15.43
Average Volume 171435 Forward Eps -2.35 Recommendation Key none
Compensation As Of Epoch Date 1 B Quick Ratio 2815.90 % Last Split Factor 1:7
Regular Market Day High 38.77 Is_sp_500 False Profit Margins 0.00 %
Debt To Equity 0.7330 Fifty Two Week High 38.93 Day High 38.77
Shares Short 2 M Regular Market Open 36.38 Industry Key biotechnology
Earnings Growth 0.00 % Revenue Growth 0.00 % Shares Percent Shares Out 0.0794
Operating Cashflow -71283000 Currency USD Time Zone Full Name America/New_York
Market Cap 1 B Is_nasdaq_100 False Zip 92014
Quote Type EQUITY Industry Biotechnology Long Name LENZ Therapeutics, Inc.
Regular Market Day Low 35.94 Held Percent Institutions 0.8637 Current Price 37.30
Address2 Suite 320 Enterprise To Ebitda -11.86 Financial Currency USD
Current Ratio 28.63 Industry Disp Biotechnology Number Of Analyst Opinions 7
Country United States Float Shares 12 M Two Hundred Day Average 19.64
Enterprise Value 810 M Forward PE -20.79 Regular Market Volume 102186
Last Dividend Date 1 B Ebitda -68337000 Exchange NMS
Go to Yahoo Finance Go to Seeking Alpha 
LENZ Therapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing therapies to improve vision in the United States.

Its product candidates include LNZ100 and LNZ101 which are in Phase III clinical trials for the treatment of presbyopia.

The company is headquartered in Del Mar, California.